UltraGreen.ai Limited (SGX:ULG)

Market Cap	543.03M
Revenue (ttm)	205.05M +41.2%
Net Income	115.44M +62.5%
EPS	0.12 -99.9%
Shares Out	1.10B
PE Ratio	4.01
Forward PE	6.29
Dividend	0.03 (5.17%)
Ex-Dividend Date	Aug 20, 2026

Volume	1,706,000
Open	0.4050
Previous Close	0.4150
Day's Range	0.3850 - 0.4050
52-Week Range	0.3800 - 1.8600
Beta	n/a
Analysts	Buy
Price Target	1.02 (+164.94%)
Earnings Date	Oct 29, 2026

About UltraGreen.ai

UltraGreen.ai Limited manufactures and sells Indocyanine Green (ICG) pharmaceutical products in the United States and internationally. It provides diagnostic imaging analytics and software solutions. The company also develops software for real-time quantification of blood perfusion during surgery, including PerfusionWorks quantification software for tissue perfusion, lymphatic mapping, and margin assessment. In addition, it offers products, such as ICG, the IC-Flow Imaging System and the UltraGreen Data Platform and other technologies related t...

• Industry: Medical - Healthcare Information Services
• Sector: Healthcare
• Founded: 2024
• Employees: 112
• Stock Exchange: Singapore Exchange
• Ticker Symbol: ULG

Financial Performance

In 2025, UltraGreen.ai's revenue was $137.94 million, an increase of 27.70% compared to the previous year's $108.02 million. Earnings were $75.63 million, an increase of 35.15%.

Financial numbers in USD

Analyst Summary

According to 4 analysts, the average rating for ULG stock is "Buy." The 12-month stock price target is $1.02, which is an increase of 164.94% from the latest price.

Price Target

$1.02

(164.94% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 9, 2026

Data Sources Report a data error